Henderson Group »

Monte Rosa Therapeutics shares owned by Henderson Group

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Henderson Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $11M 686k 16.47
2023-09-30 $114k 24k 4.79
2023-06-30 $163k 24k 6.85

More positions owned by Henderson Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Astrazeneca Ord (AZN)
Mastercard Incorporated Cl A (MA)
Lam Research Corp Com New (LRCX)
Johnson & Johnson (JNJ)
Argenx Se Sponsored Adr (ARGX)
Kla Corp Com New (KLAC)

View all positions for Henderson Group

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
TCG Crossover Management
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vestal Point Capital
Vanguard Group
Braidwell
Versant Venture Management
Vanguard Capital Management
State Street Corporation
Aisling Capital Management
Geode Capital Management
American Century Companies

View all funds holding Monte Rosa Therapeutics